Abstract: Disclosed is a method for crystallizing molecules having a molecular weight equal to or lower than about 500 Dalton in a gravity below about 0.01 g to about 0.000001 g as well as to crystalline molecules having a molecular weight equal to, or lower than, about 500 Dalton, prepared under microgravity conditions.

Abstract: There is provided a method for enhanced extraction of cannabis oil from a cannabis plant material, and a free-flowing powder consisting of particles of cannabis plant material for use in such method for enhanced extraction. The cannabis plant material is characterized by a cannabis strain and a cannabis plant part. The method comprising a step of comminuting said cannabis plant material to a powder of a preselected particle size distribution (PSD) characterized by 10?Dv(90)?100 ?m as determined by laser diffraction particle size analysis prior to extraction process. The PSD is preselected in accordance with said cannabis strain and said plant part.

Abstract: There is provided a method for enhanced extraction of cannabis oil from a cannabis plant material, and a free-flowing powder consisting of particles of cannabis plant material for use in such method. The cannabis plant material is characterized by a cannabis strain and a cannabis plant part. The method including a step of comminuting the cannabis plant material to a powder of a preselected particle size distribution (PSD) characterized by 10?Dv(90)?100 ?m as determined by laser diffraction particle size analysis prior to the extraction process, whereby the PSD is preselected in accordance with cannabis strain and the plant part.

Abstract: There is provided a method for enhanced extraction of cannabis oil from a cannabis plant material, and a free-flowing powder consisting of particles of cannabis plant material for use in such method for enhanced extraction. The cannabis plant material is characterized by a cannabis strain and a cannabis plant part. The method comprising a step of comminuting said cannabis plant material to a powder of a preselected particle size distribution (PSD) characterized by 10?Dv(90)?100 ?m as determined by laser diffraction particle size analysis prior to extraction process. The PSD is preselected in accordance with said cannabis strain and said plant part.

Abstract: Disclosed is a method for crystallizing molecules having a molecular weight equal to or lower than about 500 Dalton in a gravity below about 0.01 g to about 0.000001 g as well as to crystalline molecules having a molecular weight equal to, or lower than, about 500 Dalton, prepared under microgravity conditions.

Abstract: Processes for coating a carrier with microparticles of a drug are described. For example, a coated carrier can be obtained in a one-stage process that entails evaporating a solvent from microdroplets of a solution containing an API to obtain dry microparticles, which are then coated on the carrier.

Abstract: Processes for coating a carrier with microparticles of a drug are described. For example, a coated carrier can be obtained in a one-stage process that entails evaporating a solvent from microdroplets of a solution containing an API to obtain dry microparticles, which are then coated on the carrier.

Abstract: Processes for coating a carrier with microparticles of a drug are described. For example, a coated carrier can be obtained in a one-stage process that entails evaporating a solvent from microdroplets of a solution containing an API to obtain dry microparticles, which are then coated on the carrier.

Abstract: The present invention provides particulate tadalafil having a particle size of about 200 to about 600 microns and a process for controlling the particle size of tadalafil.

Abstract: Micronized aripiprazole Form II having a particle shape and wherein 90% or more of the particles have a particle size of about 30 ?m and the micronized aripiprazole Form II does not have more than 10% by weight of aripiprazole Type C as determined by X-ray diffraction and processes for making thereof.

Abstract: Provided is a solid particulate tadalafil having a bimodal particle size distribution.

Abstract: The present invention provides particulate tadalafil having a particle size of about 200 to about 600 microns and a process for controlling the particle size of tadalafil.

Abstract: Provided are processes for preparing crystalline forms of ezetimibe, such as ezetimibe Form A or Form B, for example, by precipitating ezetimibe from selected solvents. Alternatively, some forms may be transformed into different forms at elevated temperatures or under various humidity conditions, or by micronization. Also provided are micronized ezetimibe Form A, micronized ezetimibe Form B, and ezetimibe having a plate morphology. Pharmaceutical compositions containing these forms are particularly useful in reducing cholesterol in patients in need thereof.

Abstract: The present invention provides a pharmaceutical composition comprising a plurality of lamotrigine particles having a specific surface area of from about two to about three and a half meters per gram. Pharmaceutical compositions falling within the surface area criteria for the lamotrigine particles include those having a particle diameter equal to or less than about 100 ?m, preferably about 50 ?m, and most preferably 10 ?m. The pharmaceutical composition can be formulated into a wide variety of dosage forms.

Abstract: The present invention provides pioglitazone of defined particle size distribution. The Pioglitazone of defined particle size can be formulated into a wide variety of dosage forms.

Abstract: Provided is a process for micronization of active pharmaceutical ingredients to provide active pharmaceutical ingredients with a high specific surface area.

Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.